
Genecht Research Pvt Ltd
About
Genecht is a Contract Research Organization (CRO) specializing in BA/BE, and phase I studies. Genecht's facility is over 10,000 square feet, and Clinical and Bioanalytical units are under one roof. Our CRO has 80 beds and 4- LC-MS/MS units at our Mumbai facility. With a dedicated team of professionals and a commitment to excellence, we strive to deliver innovative solutions that meet the unique needs of our clients. Genecht entered the third year of operations and achieved the UK MHRA and EMA approval milestones. We practice ethical subject recruitment and comply with all regulatory bodies' requirements. Below mentioned are some highlights of our expertise: • Studies with lozenges, patches, films, suspension & solutions • First-in-human studies • Studies on Long-chain peptides & Biosimilars (Insulin C-peptide and Adalimumab) • Nitrosamine analysis • PK studies on animals
IN
D-400 Gayatri TTC industrial Area, Navi Mumbai, Maharashtra
400705
Privately Held
78
Pharmaceutical Manufacturing
• Studies with lozenges, patches, films, suspension & solutions • First-in-human studies • Studies on Long-chain peptides & Biosimilars (Insulin C-peptide and Adalimumab) • Nitrosamine analysis • PK studies on animals
Top Decision Makers · 1
Owner and director
Nitin Raskar
India
******@***.com
Phone
(**) *** ****
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.

